Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Granite Asia is a premier venture capital firm headquartered in Singapore, established in 2024 following the strategic reorganization of GGV Capital's Asian operations. The firm focuses on multi-stage investments across the Asia-Pacific region, with a significant emphasis on the healthcare, consumer technology, and enterprise sectors. In the healthcare space, Granite Asia targets innovative companies specializing in biotechnology, medical devices, and digital health solutions. Led by veteran investors Jenny Lee and Jixun Foo, the firm provides capital and strategic guidance to help transformative companies scale across complex regional markets. Granite Asia continues to foster innovation by leveraging its deep local expertise and extensive network within the Asian healthcare ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Granite Asia.